American Stroke Association
2024 International Stroke Conference in Phoenix, Ariz. (Feb. 7-9, 2024)

• Alexandrov AW, Shearin AJ, Mandava P, Torrealba-Acosta G, Elangovan C, Krishnaiah B, et al. Zero degree head positioning in acute large vessel ischemic stroke (ZODIAC). Presented at the American Stroke Association, 2024 International Stroke Conference in Phoenix, Ariz. (Feb. 7-9, 2024). [Oral Presentation] 

Movement Disorder Society (MDS)
27^th International Congress of Parkinson's Disease and Movement Disorders in Copenhagen, Denmark (Aug. 27-31, 2023)

• Jackson GR, Sarwar AI, Mandava P, Jamal F. Age at onset and therapeutic efficacy of primidone in essential tremor. Mov Disord. 2023;38(suppl 1):S431.  [View poster]

Neurocritical Care Society (NCS)
21^st Annual Meeting in Phoenix, Ariz. (Aug. 15-18, 2023)

• Torrealba Acosta G, James M, Laskowitz DT, Mandava P. Pooled-analysis derived model identifies CN-105 as a promising therapy to improve 90-day outcomes for patients with intracerebral hemorrhage. Neurocrit Care. 2023;39(suppl 1):S36. 
• Torrealba Acosta G, Menon G, Chang CWJ, Laskowitz DT, Mandava P. Development of predictive models for 90-day outcomes of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(suppl 1):S252. 

American Stroke Association
2023 International Stroke Conference in Dallas, Texas (Feb. 8-10, 2023)

• Barboza MA, Torrealba-Acosta G, Valdez H, Arauz A, Abanto C, Amaya PF, et al. A patient-level data Euclidean-matched analysis of reperfusion therapies in acute ischemic stroke from the Latin American Stroke Registry (LASE). Presented at the American Stroke Association, 2023 International Stroke Conference in Dallas, Texas (Feb. 8-10, 2023).  
• Torrealba-Acosta G, Barboza MA, Arauz A, Amaya PF, Ameriso SF, Cano V, et al. Favorable mechanical thrombectomy outcomes from the Latin American Stroke Registry (LASE) and resilient trial compared to a 90-day functional and mortality predictive model. Presented at the American Stroke Association, 2023 International Stroke Conference in Dallas, Texas (Feb. 8-10, 2023). [Oral Presentation] 

Neurocritical Care Society (NCS)
20^th Annual Meeting in San Antonio, Texas (Oct. 17-21, 2022)

• Escamilla-Ocañas CE, Torrealba-Acosta G, Mandava P, Qasim MS, Gutiérrez-Flores B, Bershad E, et al. Patient and cost-benefit of utilizing checklists in the Neurocritical Care Unit. Presented at the Neurocritical Care Society (NCS), 20^th Annual Meeting in San Antonio, Texas (Oct. 17-21, 2022).  

American Academy of Neurology (AAN)
74^th Annual Meeting in Seattle, Wash. (April 2-7, 2022)

• Torrealba-Acosta G, Escamilla-Ocanas C, Mandava P, Bershad E, Hirzallah M, Venkatasubba Rao C, et al. Implementation of systematic safety checklists in a neurointensive care unit: A quality and improvement study. Neurology. 2022;98(18 suppl):. [Oral Presentation] 

Institute of Electrical and Electronics Engineers (IEEE)
2021 IEEE 18^th India Council International Conference (INDICON) in Guwahati, India (Dec. 19-21, 2021)

• Divya B, Parameshwaran Nair R, Prakashini K, Girish Menon R, Litvak P, Mandava P, et al. A more generalizable DNN based automatic segmentation of brain tumors from multimodal low-resolution 2D MRI. 2021 IEEE 18^th India Council International Conference (INDICON), 2021, pp. 1-5, doi: 10.1109/INDICON52576.2021.9691588. 

American Stroke Association
Virtual 2021 International Stroke Conference (March 17-19, 2021)

• Mandava P, Hegde A, Sandesh O, Menon G. Google Auto ML based prediction of outcomes in intracerebral hemorrhage - Bringing machine learning to clinicians. Stroke. 2021;52 Suppl 1:P421. 
• Mandava P, Torrealba-Acosta G, Barboza MA, Fernandez-Morales H, Qasim M, Litvak P, et al. Outcomes after thrombolysis for ischemic stroke in Costa Rica compare favorably with international cohorts. Stroke. 2021;52 Suppl 1:P17. 

Joint European Stroke Conference and World Stroke Congress
Virtual Conference (Nov. 7-9, 2020)

• Katsanos AH, Tsivgoulis G, Mandava P, Kohrmann M, Soinne L, Barreto A, et al. Pulse pressure variability is associated with unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis in a phase III randomized-controlled clinical trial. Int J Stroke. 2020;15(1 suppl):111-2. 
• Torrealba-Acosta G, Barboza-Elizondo M, Litvak P, Fernandez-Morales H, Rothlisberger T, Tsivgoulis G, et al. Response to thrombolysis in Costa Rican patients compared with NINDS and CLOTBUST-ER cohorts. Int J Stroke. 2020;15(1 suppl):741. 
• Tsivgoulis G, Katsanos AH, Eggers J, Larrue V, Thomassen L, Grotta J, et al. Moderators of the efficacy of sonothrombolysis in acute ischaemic stroke patients with large vessel occlusion: A systematic review and international collaborative individual patient data meta-analysis. Int J Stroke. 2020;15(1 suppl):118-9. 
• Tsivgoulis G, Katsanos AH, Mandava P, Kohrmann M, L Soinne, Barreto A, et al. Blood pressure excursions are associated with unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis in a phase III randomized-controlled clinical trial. Int J Stroke. 2020;15(1 suppl):109-10. 

American Stroke Association
2020 International Stroke Conference in Los Angeles, Calif. (Feb. 19-21, 2020)

• Litvak P, Medikonda J, Menon G, Mandava P. High accuracy of predictive models for SAH using different machine learning approaches. Stroke. 2020;51 Suppl 1:TP458. 
• Murthy SB, Cho S-M, Gupta A, Shoamanesh A, Avadhani R, Gruber J, et al. Diffusion weighted imaging lesions in patients with acute intracerebral hemorrhage: A pooled analysis of individual patient data from MISTIE-III, ATACH-II, I-DEF, and ERICH. Stroke. 2020;51 Suppl 1:18. 
• Tsivgoulis G, Katsanos AH, Eggers J, Larrue V, Thomassen L, Grotta JC, et al. Safety and efficacy of sonothrombolysis in acute ischemic stroke patients with large vessel occlusion: International collaborative individual patient data meta-analysis. Stroke. 2020;51 Suppl 1:106. 

European Stroke Organisation (ESO)
5^th Conference in Milan, Italy (May 22-24, 2019)

• Alexandrov A, Tsivgoulis G, Kohrmann M, Katsanos A, Soinne L, Barreto AD, et al. Endovascular equipoise shift during a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke. Eur Stroke J. 2019;4(1 Suppl):AS02-206. 
• Luthra A, Harini JA, Medikonda J, Mandava P, Aaron S, Rajesh KN, et al. Constitution (Prakriti) as defined by traditional Indian medicine is a risk factor for stroke. Eur Stroke J. 2019;4(1 Suppl):AS22-068. 
• Mandava P, Medikonda J, Khan A, Litvak P, Menon G. Machine learning to predict subarachnoid hemorrhage outcomes. Eur Stroke J. 2019;4(1 Suppl):AS28-028. 

American Stroke Association
2019 International Stroke Conference in Honolulu, Hawaii (Feb. 6-8, 2019)

• Mandava P, Saeed O, Qureshi AI, Kent TA. Development of outcome models for intracerebral hemorrhage using patient level data from ATACH-II and information theory to identify the best predictors. Stroke. 2019;50 Suppl 1:TP435. 
• Rushworth D, Mathews A, Mandava P. Race and gender differences in mortality due to spontaneous subarachnoid hemorrhage. Stroke. 2019;50 Suppl 1:TP552. 

European Stroke Organisation (ESO)
4^th Conference in Gothenburg, Sweden (May 16-18, 2018)

• Hegde A, King Z, Ormseth C, Falcone G, Hwang D, Sansing L, et al. NIHSS is a better predictor of outcomes in ICH compared to GCS and hematoma volume. Information theory approaches applied to databases from India and U.S.. Eur Stroke J. 2018;3(1 Suppl):AS20-048. 

American Academy of Neurology (AAN)
70^th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)

• Spiegel L, Pham L, Mandava P. The danger of flying with acute otitis media, which may result in Gradenigo's syndrome. Neurology. 2018;90(15 Suppl):P5.129.  [View poster]

American Stroke Association
2018 International Stroke Conference in Los Angeles, Calif. (Jan. 24-26, 2018)

• Shah N, Shah V, Venkatasubba Rao CP, Kent TA, Mandava P. Systematic review identified some early phase promising therapeutics for subarachnoid hemorrhage. Stroke. 2018;49:A41. [Oral Presentation] 

Neurocritical Care Society (NCS)
15^th Annual Meeting in Waikoloa, Hawaii (Oct. 10-13, 2017)

• Mandava P, Shah N, Shah V, Rao CP, Kent TA. Identification of promising therapeutics for subarachnoid hemorrhage. Neurocrit Care. 2017;27(2 Suppl):S382. 

European Stroke Organisation (ESO)
3^rd Conference in Prague, Czech Republic (May 16-18, 2017)

• Da Q, Mandava P, Shah N, Cruz M, Thiagarajan P, Kent T. Genetics, proteomics, metabolomics, and biomarkers unexpected conformational change of platelet glycoprotein IB (GPIB) receptor after rt-PA treatment of large vessel ischemic stroke. Eur Stroke J. 2017;2(1 Suppl):AS14-038. 
• Shah N, Shah V, Rao C, Mandava P, Kent T. SAH, aneurysms and vascular malformations identification of promising therapeutics for subarachnoid hemorrhage. Eur Stroke J. 2017;2(1 Suppl):AS27-030. 

6^th World Intracranial Hemorrhage Conference (WICH)
Baltimore, Md. (May 1-3, 2017)

• Mandava P, Murthy SB, Samson Y, Kent TA. Testing treatments for intracranial hemorrhage compared to a pooled outcome model accounts for variability in baseline conditions and identifies potentially positive, neutral, and harmful interventions. Presented at the 6^th World Intracranial Hemorrhage Conference (WICH), Baltimore, Md. (May 1-3, 2017). [Oral Presentation] 
• Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, et al. Resumption of anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis. Presented at the 6^th World Intracranial Hemorrhage Conference (WICH), Baltimore, Md. (May 1-3, 2017).  

American Stroke Association
2017 International Stroke Conference in Houston, Texas (Feb. 22-24, 2017)

• Da Q, Mandava P, Cruz M, Thiagarajan P, Kent TA. Unexpected conformational change of platelet glycoprotein Ib (GPIb) receptor after rt-PA treatment of large vessel ischemic stroke. Stroke. 2017;48:AWP66. 
• Kent TA, Rea HC, Dalmeida W, Fabian RH, Ayata C, Mandava P. Incorporating biological variability in experimental stroke to better mimic human stroke. Stroke. 2017;48:AWP281. 
• Kent TA, Rea HC, Dalmeida W, Fabian RH, Tour JM, Nilewski LG, et al. A novel catalytic antioxidant carbon nanoparticle improves outcome in hyperglycemic stroke in rats at clinically relevant recanalization times. Stroke. 2017;48:A61. [Platform Presentation] 

American Heart Association
2016 Scientific Sessions in New Orleans, La. (Nov. 12-16, 2016)

• Mandava P, Martini SR, Shah VA, Fabian RH, Kent TA. Prior use of intravenous rt-PA improves outcome in endovascular stent retriever trials for acute large vessel ischemic stroke. Presented at the American Heart Association, 2016 Scientific Sessions in New Orleans, La. (Nov. 12-16, 2016).   [View poster]

Neurocritical Care Society (NCS)
14^th Annual Meeting in National Harbor, Md. (Sept. 15-18, 2016)

• Mandava P, Martini S, Shah V, Fabian R, Kent T. Intravenous rt-PA use prior to endovascular thrombectomy increases probability of good outcome in acute ischemic stroke. Neurocrit Care. 2016;25(1 Suppl):S122. 
• Mandava P, Murthy S, Samson Y, Kent T. Modeling outcome after intracerebral hemorrhage indicates no benefit and potential harm from aggressive blood pressure management. Neurocrit Care. 2016;25(1 Suppl):S21. [Platform Presentation] 

American Stroke Association
2016 International Stroke Conference in Los Angeles, Calif. (Feb. 17-19, 2016)

• Mandava P, Martini SR, Shah VA, Fabian RH, Kent TA. Factors influencing differential outcomes in stent retriever trials: Comparison to a new outcome model based on percent utilization of rt-PA. Stroke. 2016;47:WMP1. 

American Stroke Association
2015 International Stroke Conference in Nashville, Tenn. (Feb. 11-13, 2015)

• Mandava P, Rosso C, Samson Y, Kent TA. Multi-center experience with low dose intravenous abciximab in large vessel posterior circulation stroke. Stroke. 2015;46:AWMP30. 
• Mandava P, Samson Y, Kent TA. Modeling outcome after intracerebral hemorrhage indicates no benefit from lowering blood pressure. Stroke. 2015;46:A95. [Oral Presentation] 

American Stroke Association
2014 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2014)

• Barreto AD, Mandava P, Guerrero W, Shen L, Grotta JC, Kent TA. Combination argatroban and TPA for acute ischemic stroke: A matched case-control analysis. Stroke. 2014;45:AWP52. 
• Mandava P, Shah SD, Sarma AK, Dalmeida D, Kent TA. A pooled analysis indicates the promise and pitfalls of improving upon intravenous rt-PA for ischemic stroke. Stroke. 2014;45:AWP60. 

American Neurological Association (ANA)
138^th Annual Meeting in New Orleans, La. (Oct. 13-15, 2013)

• Shah S, Mandava P, Sarma AK, Kent TA. A pooled analysis identifies the potential to improve upon intravenous rt-PA. Ann Neurol. 2013;74 Suppl 17:S10. [Oral Presentation]  [View poster]

Neurocritical Care Society (NCS)
11^th Annual Meeting in Philadelphia, Penn. (Oct. 1-4, 2013)

• Mandava P, Murthy SB, Dalmeida W, Hannawi Y, Wu EY, Kent TA. Generation of a pooled outcome model for traumatic brain injury to use for prediction of potential trial success. Neurocrit Care. 2013;19(1 Suppl):S74. 

American Heart Association/American Stroke Association
2013 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2013)

• Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al. Outcomes after tPA in African American women with explicit consideration of baseline factors. Stroke. 2013;44(2_MeetingAbstracts):ATP62. 
• Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al. Extending the time window with low dose IV abciximab in acute non-lacunar stroke. Stroke. 2013;44(2_MeetingAbstracts):AWP68. 

American Stroke Association
2013 International Stroke Conference in Honolulu, Hawaii (Feb. 6-8, 2013)

• Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al. Outcomes after tPA in African American women with explicit consideration of baseline factors. Stroke. 2013;44:ATP62. 
• Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al. Extending the time window with low dose IV abciximab in acute non-lacunar stroke. Stroke. 2013;44:AWP68. 

Neurocritical Care Society (NCS)
10^th Annual Meeting in Denver, Colo. (Oct. 4-7, 2012)

• Mandava P, Shah S, Murthy SB, Kent TA. Low dose IV Abciximab for acute ischemic stroke patients ineligible for IV rt-PA. Neurocrit Care. 2012;17:S5. [Platform Presentation] 

American Stroke Association
2012 International Stroke Conference in New Orleans, La. (Feb. 1-3, 2012)

• Krumpelman CS, Mandava P, Kent TA. Error rate estimates for the modified Rankin Score "Shift Analysis" using information theory modeling. Stroke. 2012;43(2_MeetingAbstracts) Suppl 1:A2372. 
• Mandava P, Brooks ME, Krumpelman CS, Kent TA. A new more sensitive method to assess balance among stroke trial populations. Stroke. 2012;43(2_MeetingAbstracts) Suppl 1:A2374. 
• Mandava P, Shah S, Sarma AK, Murthy SB, Kent TA. A systematic analysis of endovascular and intravenous therapy for ischemic stroke based on time window using a novel outcome model. Stroke. 2012;43(2_MeetingAbstracts) Suppl 1:A3260. 

European Federation of Neurological Societies (EFNS)
15^th Congress in Budapest, Hungary (Sept. 10-13, 2011)

• Mandava P, Sarma AK, Shah S, Kent TA. A systematic analysis of intravenous and endovascular therapy for ischemic stroke using a novel predictive outcome model. Eur J Neurol. 2011;18 (Suppl 2):38. 

European Stroke Conference (ESC)
20^th Annual Meeting in Hamburg, Germany (May 24-27, 2011)

• Mandava P, Sarma A, Anderson J, Wehner B, Kent T. How gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA. Cerebrovasc Dis. 2011;31(suppl 2):263-4. [Previously Presented] 
• Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA. Hyperglycemia is an independent risk factor for poor outcome after rtPA only in the large artery stroke subtype. Cerebrovasc Dis. 2011;31(suppl 2):255. 
• Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA. Novel analysis methodology indicates extended window low-dose IV abciximab improves outcome. Cerebrovasc Dis. 2011;31(suppl 2):126. 

American Stroke Association
2011 International Stroke Conference in Los Angeles, Calif. (Feb. 8-11, 2011)

• Mandava P, Munoz M, Dalmeida W, Sarma K, Brooks MA, Anderson J, et al. Hyperglycemia worsens outcome after rt-PA in the large artery stroke subtype. Stroke. 2011;42:e84. 
• Mandava P, Munoz M, Sarma K, Brooks MA, Dalmeida W, Anderson J, et al. Gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA. Stroke. 2011;42:e164. 

European Stroke Conference (ESC)
19^th Annual Meeting in Barcelona, Spain (May 25-28, 2010)

• Mandava P, Kent TA. Rebalancing the NINDS rt-PA trial. Proceedings of the European Stroke Conference 19th Annual Meeting; 2010 May 25-28; Barcelona, Spain. 

European Stroke Conference (ESC)
18^th Annual Meeting in Stokholm, Sweden (May 26-29, 2009)

• Mandava P, Anderson J, Dalmeida W, Kent TA. Platelet inhibition may explain results with abciximab in the treatment of acute ischemic stroke. Cerebrovasc Dis. 2009;27(Suppl 6):16. 
• Mandava P, Kent TA. A method to generate a control population for acute ischemic stroke trials: Validation with NINDS and application to a phase 1 treatment series. Cerebrovasc Dis. 2009;27(Suppl 6):172-3. 

American Stroke Association
2009 International Stroke Conference in San Diego, Calif. (Feb. 17-20, 2009)

• Mandava P, Kent TA. Restoring balance: A method to adjust for randomization imbalances in stroke clinical trials. Stroke. 2009;40(4):e158. 

World Stroke Organization (WSO)
10^th International Symposium on Thrombolysis and Acute Stroke Therapy in Budapest, Hungary (Sept. 21-23, 2008)

• Mandava P, Kent TA. A systematic analysis of intravenous rt-PA vs. endovascular therapy with respect to therapeutic time window in acute ischemic stroke. Int J Stroke. 2008;3(Suppl 1):458. 
• Mandava P, Kent TA. Low-dose intravenous abciximab and heparin for large vessel acute ischemic stroke: Comparison with natural history models. Int J Stroke. 2008;3(Suppl 1):242-3. 

European Stroke Conference (ESC)
17^th Annual Meeting in Nice, France (May 13-16, 2008)

• Mandava P, Kent TA. Improved prediction of treatment success in stroke based on pooled control arms. Cerebrovasc Dis 2008;25(suppl 2):61-2. 

American Stroke Association
2008 International Stroke Conference in New Orleans, La. (Feb. 20-22, 2008)

• Mandava P, Anderson J, Thiagarajan P, Kent TA. Platelet aggregation unit inhibition to guide abciximab therapy in acute ischemic stroke: preliminary results. Stroke. 2008;39(2):603. 
• Mandava P, Kent TA. A method to predict stroke trial success based on pooled control arms. Stroke. 2008;39(2):532-3. 

American Stroke Association
2007 International Stroke Conference in San Francisco, Calif. (Feb. 7-9, 2007)

• Mandava P, Kent TA. Factors associated with good outcome following intra-arterial therapy for acute ischemic stroke: a severity-adjusted systematic review. Stroke. 2007;38:501. 

American Stroke Association
2006 International Stroke Conference in Kissimmee, Fla. (Feb. 16-18, 2006)

• Mandava P, Kent TA. A systematic review of mortality and functional outcome in catheter-based therapy for acute ischemic stroke: comparison to predictive models. Stroke. 2006;37:654. 
• Martini S, Anderson JA, Mandava P, Kent TA. Relationship between admission glucose and outcome in the intravenous abciximab/heparin in acute stroke phase 1 study. Stroke. 2006;37:661. 

American Stroke Association
30^th International Stroke Conference in New Orleans, La. (Feb. 2-4, 2005)

• Mandava P, Kent TA. Resolution of "Dense Dot Sign" after acute ischemic stroke is associated with better outcome. Stroke. 2005;36(2):439. 

International Stroke Society (ISS)
5^th World Stroke Congress in Vancouver, British Columbia, Canada (June 23-26, 2004)

• Mandava P, Lick SD, Rahman AM, Kent TA. Intravenous abciximab in complicated cardioembolic stroke patients with high NIHSS. Proceedings of the International Stroke Society 5th World Stroke Congress; 2004 June 23-26; Vancouver, British Columbia, Canada. 

International Stroke Society (ISS)
8^th International Symposium on Thrombolysis and Acute Stroke Therapy in Whistler, British Columbia, Canada. (June 19-22, 2004)

• Mandava P, Reddy K, Kent TA. Reversibility of dense CT "dot" sign predicts recovery after abciximab and heparin. Proceedings of the International Stroke Society 8th International Symposium on Thrombolysis and Acute Stroke Therapy; 2004 June 19-22; Whistler, British Columbia, Canada.